“Comparative effectiveness research received a significant boost from Recovery Act (ARRA) money – $1.1 billion has been earmarked for this type of research. ARRA provides $300 million for the Agency for Healthcare Research and Quality (AHRQ), $400 million for the National Institutes of Health (NIH), and $400 million for the Office of the Secretary of Health and Human Services (HHS). These funds are to support studies assessing the comparative effectiveness of health care treatment and strategies, through efforts that (1) conduct research on clinical outcomes, effectiveness and appropriateness of treatments for various disease and conditions, and (2) encourage the development and use of clinical registries, data networks and other forms of electronic data to generate or obtain outcomes data.”
Article
Robert Rowley, EHR Bloggers, 15 December 2009
